1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with manoalide in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (manoalide) | Trials (manoalide) | Recent Studies (post-2010) (manoalide) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 115 | 0 | 12 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | manoalide (IC50) |
|---|---|---|---|
| Phosphatidylcholine 2-acylhydrolase | Apis mellifera (honey bee) | 0.04 | |
| Acidic phospholipase A2 beta | Crotalus adamanteus (eastern diamondback rattlesnake) | 0.4 | |
| Phospholipase A2 | Apis mellifera (honey bee) | 5.1667 | |
| Phospholipase A2 | Homo sapiens (human) | 3.9 | |
| Phospholipase A2, membrane associated | Homo sapiens (human) | 3.9 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.5 | |
| Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 3.9 | |
| DNA polymerase kappa | Homo sapiens (human) | 4.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, EA; Glaser, KB; Lister, MD; Ulevitch, RJ | 1 |
| Braquet, P; Freitas, JC; Lavaud, P; Mencia-Huerta, JM; Rodrigue, F | 1 |
| Bauer, J; Carlson, RP; Glaser, KB; Hartman, DA; Lock, YW; Sung, ML; Walter, T | 1 |
| Dohi, T; Kitayama, S; Kurihara, H; Mizuno, N; Morita, K; Shibata, K; Shinohara, H; Yoshino, H | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and manoalide
| Article | Year |
|---|---|
Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide.
Topics: Acetophenones; Calcimycin; Cell Line; Dinoprostone; Fatty Acids, Unsaturated; Kinetics; Macrophages; Melitten; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Substrate Specificity; Terpenes | 1989 |
Inhibition of platelet aggregation by manoalide: preliminary results.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Platelet Activating Factor; Platelet Aggregation; Rabbits; Terpenes | 1988 |
Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Topics: Animals; Anti-Inflammatory Agents; Eicosanoids; Ellagic Acid; Homosteroids; Humans; Inflammation; Macrophages; Male; Mice; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Sesterterpenes; Skin; Synovial Fluid; Terpenes | 1995 |
Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Azepines; Calcium; Cytosol; Enzyme Inhibitors; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Terpenes; Tosylphenylalanyl Chloromethyl Ketone; Triazoles | 2000 |